Skip to content

To evaluate the efficacy of pratham triphala rasayan in mutraghat

Randomized, Controlled, Clinical Study to evaluate the efficacy of Pratham Trifala Rasayana as adjuvant therapy in Mutraghata with special reference to Chronic Renal Failure.

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023290
Enrollment
122
Registered
2020-02-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N181- Chronic kidney disease, stage 1

Interventions

Intervention1: Pratham Triphala Rasayan (Haritaki Bibhitaki Amalaki): Haritaki 5 gm in the morning empty stomach Bibhitaki 5 gm in the noon before lunch Amalaki 5 gm in the noon after lunch for 90 da

Sponsors

Sanjivani Jadhao Rathod
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Pre diagnosed patients of CKD of Stage I to III 2. Both sexes male and female. 3. Willing to Consent & Participate. 4. Age 25 to 65 years. 5. Patients having classical sign and symptoms of CKD such as Shotha (oedema), fatigability (weakness), Swaskashtata (Dyspnoea), anannabhilasha (anorexia), Panduta (less haemoglobin) etc.

Exclusion criteria

Exclusion criteria: 1. Acute Renal Failure 2. Uremic Coma 3. Known Patients of Renal Artery Stenosis 4. Age 65 years. 5. Patients of Carcinoma 6. Participate in other clinical trial within 30 days prior to this trial. 7. History of previous kidney transplant. 8. HIV and VDRL infected patients will be excluded.

Design outcomes

Primary

MeasureTime frame
Improvement in urinary output Reduction in edema Increase in appetite Improvement in fatigueTimepoint: 90 days

Secondary

MeasureTime frame
Improvement in signs and symptoms of CKDTimepoint: 90 days

Countries

India

Contacts

Public ContactSanjivani Jadhao Rathod

MUHS Nashik

vaidyarajankulkarni@gmail.com8007229141

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026